Failure to Meet Overseas Expansion Plans and Additional Investment
First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2020.
The whole theme swung hardest in 2025: 5 of 10 companies on the "Worse" side.
4 other companies' latest entry also says "Restated".
- FY2020RestatedAnnual report
「If we make additional investments to expand the business in the future, or if the business does not progress as planned, this could affect the performance of our Group.」
The possibility of an impact on performance due to additional investment or failure to meet plans in overseas expansion continues. - FY2018RestatedAnnual report
「If we make additional investments to expand this business in the future, or if the business does not progress as planned, this could affect the performance of our Group.」
The possibility of an impact on performance due to additional investment or failure to meet plans in overseas expansion continues. - FY2017RestatedAnnual report
「If we make additional investments to expand this business in the future, or if the business does not progress as planned, this could affect the performance of our Group.」
The possibility of an impact on performance due to additional investment or failure to meet plans in overseas expansion continues. - FY2016First statedAnnual report
「If we make additional investments to expand this business in the future, or if the business does not progress as planned, this could affect the performance of our Group.」
For overseas expansion to support international joint clinical trials, additional investment and failure to meet plans are identified as risks.